Texas BioMed

A San Antonio collaborative is developing treatments for antibiotic-resistant infections using viruses known as phages. The effort is urgent as infections that don't respond to antibiotics are projected to kill 39 million people by 2050.

One of humanity's great quests made microscopic in the aging intestines of tiny monkeys.

Texas Biomedical Research Institute, a nonprofit infectious disease research facility in San Antonio, withdrew its $11 million bond project request from the city to expand its campus infrastructure.

New research out of South Africa and the UK have found that the omicron variant dramatically reduces vaccine effectiveness in the Pfizer-BioNTech COVID-19 vaccine. However, there are ways to minimize omicron's impact in the United States.

Texas Biomed's planned expansion of its animal care facilities will allow the institute to increase its population of nonhuman primates available for research by up to 1,000.

On this episode of Petrie Dish, host Bonnie Petrie speaks with Dr. Tracey Baas of Texas Biomedical Institute about timing, mixing and matching, who should be getting the booster and more.

Dr. Larry Schlesinger urges Texans to keep wearing masks.

The state of Texas is steadily approaching its one millionth COVID-19 case. Holiday celebrations have been canceled, big life events have been postponed until further notice and mask fatigue is setting in. But in San Antonio, several companies are working to help the United States return to some sort of normalcy.

On Fronteras:The Strong Heart Study has tracked the heart health of Native American populations since 1988. (0:00)Family and friends remember Dr. Alfonso…

The Department of Defense is funding research in San Antonio to see if a new vaccine can prevent birth defects in babies of women exposed to the Zika…